Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001213900-25-059797
Filing Date
2025-06-30
Accepted
2025-06-30 17:34:18
Documents
1
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 6867
  Complete submission text file 0001213900-25-059797.txt   8396
Mailing Address 1600 BROADWAY SUITE 1360 DENVER CO 80202
Business Address
Smith Ryan Lewis (Reporting) CIK: 0001619129 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38105 | Film No.: 251093450

Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Issuer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)